Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04452955 · ClinicalTrials.gov registry record · Phase 2

A Study to Assess Safety and Efficacy of PRL3-Zumab in Patients With Solid Tumors

A Phase 2 study of Solid Tumor, sponsored by Intra-IMMUSG Pte.

Active
Registry status
Phase 2
Development phase
51
Enrollment target
5
Study locations

NCT04452955 is a Phase 2 study of Solid Tumor that is active but no longer recruiting, run by Intra-IMMUSG Pte. The registered enrollment target is 51 participants, below the 221-participant average among 196 other Solid Tumor trials with a reported enrollment target (77% lower). The trial reports 5 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04452955, a Phase 2 study of Solid Tumor, is active but no longer recruiting, sponsored by Intra-IMMUSG Pte.

ACTIVE NOT RECRUITING
Registry status
Phase 2
Development phase
51 participants
Enrollment target
5
Study locations

Study Summary

This is a multi-center, Phase 2, open-label, single dose level study of PRL3-zumab monotherapy in patients with unresectable or metastatic solid tumor.

Conditions Studied

Solid Tumor

Interventions

  • BIOLOGICAL PRL3-zumab

Study Locations (5)

California

  • St. Jude Medical Center - Fullerton
  • The Angeles Clinic - Los Angeles

Arizona

  • HonorHealth Research - Scottsdale

Kentucky

  • Norton Healthcare - Louisville

Nevada

  • Comprehensive Cancer Centers of Nevada - Las Vegas

Trial Details

FieldValue
Enrollment Target 51 participants
Start Date 2020-12-12
Est. Completion 2026-03-01
Phase Phase 2

Sponsor

Intra-IMMUSG Pte

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04452955

The ClinicalTrials.gov registry entry for NCT04452955 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 221-participant average among 196 other Solid Tumor trials with a reported enrollment target (77% lower). The listed sponsor is Intra-IMMUSG Pte, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Solid Tumor appearing as the primary indexed condition, and to 1 intervention - of which PRL3-zumab is the first listed.

NCT04452955 reports 5 study locations spanning 4 distinct geographic areas - top geographies include California, Arizona, Kentucky.

Frequently Asked Questions

What is clinical trial NCT04452955 about?

NCT04452955 is a clinical study titled "A Study to Assess Safety and Efficacy of PRL3-Zumab in Patients With Solid Tumors". This is a multi-center, Phase 2, open-label, single dose level study of PRL3-zumab monotherapy in patients with unresectable or metastatic solid tumor.

What is the current status of trial NCT04452955?

This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 51 participants. The study started on 2020-12-12. Estimated completion is 2026-03-01.

What conditions does trial NCT04452955 study?

This clinical trial studies the following conditions: Solid Tumor.

What interventions are being tested in trial NCT04452955?

The interventions under investigation include: PRL3-zumab (BIOLOGICAL).

Who is sponsoring clinical trial NCT04452955?

This trial is sponsored by Intra-IMMUSG Pte, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04452955 being conducted?

This trial has 5 study locations across Arizona, California, Kentucky, Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Solid Tumor

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Solid Tumor

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.